|
Post by stevil on Nov 9, 2015 20:01:12 GMT -5
Thank you for replying Stevil. No one here dislikes you, or at least I don't. How can someone who holds 25K shares, get so down on the company? You stated that you're underwater on this. Why do you try to bring it down further then? You're in med school, yet put a substantial amount of cash into MNKD, now struggling as a result, but you still post neg on it? Makes no sense to me, but whatever. Aloha. I don't try to bring it down further. Can you please point me to those posts? I'm not the CEO of the company. Me being one person isn't going to bring the company down. While many on here have shared that they're happy to be contributing to mankind (small m, one n), we're not here for charity. We're here to invest in a company and receive a positive return on our investment. Many here thought they'd get rich quick and easy on this company. I was guilty of that also when I first invested. But along with Al, Hakan, Matt, and probably everyone else not a short, we're all learning the hard way about why this was plagued with so many roadblocks and how hard they are to overcome. So no, my mission isn't to drive the share price down further. I've stated publicly that my meager holding will stay with me. I'm going down with the ship unless BK is imminent and inevitable. My mission is to be the yin to the yang on this board. To balance out the pumpers and to temper expectations so more people don't keep dumping more money into this stock. There are better options right now. I've made 20% alone in the past month in one of my oil refinery stocks. MNKD could be a good investment again some day. Today is not that day. I can't fix this company. That's management's job. I'll buy more shares and offer my support once they show me it's a good investment.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 9, 2015 20:02:13 GMT -5
Mind: Mahalo for the kind welcome. Things fell apart for me on the other board and I closed my account there. I have not bird-dogged my script yet for Afrezza. Why? Cuz I'm waiting for it to get easier to obtain! It's that simple. I'm not going thru with all the hassle/roadblocks to get it. My control is excellent so I can wait. Once things get easier, and I don't have educate my doctor on what Afrezza is, (she had never heard of it), I will go on it.
|
|
|
Post by lakers on Nov 9, 2015 20:03:30 GMT -5
"1. jay olsen GS - 25 mil milestone that should be coming due to manufactuering when is it coming - hakan, no, no payment coming due now. only additional payment coming due to R&D. Any time soon? eh, ah, eh, no timing on that one." I have said all along, it was not mfgr but dev milestone bonus. "I forgot to mention $25M milestone bonus for qualifying Sanofi's insulin for Afrezza, which could be due 1Q16. It's categorized as dev" Read more: mnkd.proboards.com/thread/3875/3q15-mon-convene-half-decide#ixzz3r2ty8YTz
|
|
|
Post by pktrump on Nov 9, 2015 20:04:40 GMT -5
Key Stone cops is what we need:
'A Zeal and a tizzy' in advertising and understanding by Diabetics.
|
|
|
Post by compound26 on Nov 9, 2015 20:07:51 GMT -5
My fear is they cannot afford to pay the right people (people with proven resumes) their asking price to run this company. So we're either stuck with what we've got or we pick someone with a lot of potential that may not have a lot of experience and hope for the best. That's a little extreme. These guys did a great technical job, did great job with regulators, great jobs with patents, but then came Sanofi and all of this QUIET period about what we do not know. If this were a Silicon Valley Co. it would be worth multiples of ten billion. That's all I have to say. It is easy to say the management did not do well with hinder-sight. I think neither us (or most of us here), nor the management, nor even Sanofi expect that the uptick for the scripts were this slow. Exubera had better script numbers than Afrezza. How could anyone have thought than Afrezza will have a slower start than Exubera? The better choice would of course for the management to offer the shares to the market when the PPS was around $7. If only the scripts are double or triple the current count, management wouldn't be subject to such pressure right now. But on the other hand, if you think how much resources Pfizer probably put into the marketing of Exubera, you would not be surprised Afrezza's sales are so slow at this point. Given the unexpected slow uptick of scripts and the unprecedented shorting on Mannkind, I think the TASE offering overall is a pretty good solution to the cash situation. Kind of feeling that the TASE offering will be a turning point to Mannkind like when Ford had a second offering at $5 in 2009/2010 or when Solomon Brothers did the public offering for Geico to buttress its capital back in the 1970s.
|
|
|
Post by stevil on Nov 9, 2015 20:14:47 GMT -5
Hard to say how much more SNY could do if they tried, but their marketing and insurance efforts have been subpar. Look no further than Toujeo. When they have a desire to get something done, they get it done. SNY is just as much a problem as our management.
There's no doubt in my mind, though, that the script count would be a multiple of what it is now if SNY was dedicated to properly advertising this product. And as some have stated on here before, hire an Apple consultant and make the dreamboat hip and cool. The younger generations are going to be the biggest adopters of Afrezza.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 9, 2015 20:19:29 GMT -5
No worries Stevil, and glad to hear you're making money in oil. I'm glad you post here, glad you enjoy it, but personally will no longer post responses to what you may have to say; not out of disrespect, but I've "been here, done this" with other soft-bashers and frankly, am quite tired of it.
|
|
|
Post by stevil on Nov 9, 2015 20:22:54 GMT -5
No worries Stevil, and glad to hear you're making money in oil. I'm glad you post here, glad you enjoy it, but personally will no longer post responses to what you may have to say; not out of disrespect, but I've "been here, done this" with other soft-bashers and frankly, am quite tired of it. I appreciate that. And I'll be going back into my hole soon. I just got back from a week off and I'm finding it's hard to get the wheels turning again. I won't have time to post much again soon, probably better for everyone ha. I appreciate your sentiments. And no hard feelings. I'm learning it's better to agree to disagree with 90% of this board. Just hope I'm wrong!
|
|
|
Post by MD2017 on Nov 9, 2015 20:27:01 GMT -5
No worries Stevil, and glad to hear you're making money in oil. I'm glad you post here, glad you enjoy it, but personally will no longer post responses to what you may have to say; not out of disrespect, but I've "been here, done this" with other soft-bashers and frankly, am quite tired of it. I appreciate that. And I'll be going back into my hole soon. I just got back from a week off and I'm finding it's hard to get the wheels turning again. I won't have time to post much again soon, probably better for everyone ha. I appreciate your sentiments. And no hard feelings. I'm learning it's better to agree to disagree with 90% of this board. Just hope I'm wrong! Stevil, hope you don't mind my asking, but are you a physician? Couldn't help but notice your "whitecoat" Cheers, Derek
|
|
|
Post by mindovermatter on Nov 9, 2015 20:30:20 GMT -5
Mind: Mahalo for the kind welcome. Things fell apart for me on the other board and I closed my account there. I have not bird-dogged my script yet for Afrezza. Why? Cuz I'm waiting for it to get easier to obtain! It's that simple. I'm not going thru with all the hassle/roadblocks to get it. My control is excellent so I can wait. Once things get easier, and I don't have educate my doctor on what Afrezza is, (she had never heard of it), I will go on it. Sorry to hear that but IHUB is like the wild west. This is a much more civilized board. Hopefully the script process will get easier by the early part of 2016.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 9, 2015 20:34:56 GMT -5
Yup, IMO the entire process from insurance coverage, to making it easy to get a script will be dealt with effectively and the floodgates of those wanting Afrezza will burst open. That is my belief for 2016. Don't for a second think that there is not a ton of work going on behind the scenes to make this all happen. Hey, I trust MNKD and the man behind it, Dr. Al Mann. This is where I stand on the entire matter.
|
|
|
Post by stevil on Nov 9, 2015 20:40:18 GMT -5
I appreciate that. And I'll be going back into my hole soon. I just got back from a week off and I'm finding it's hard to get the wheels turning again. I won't have time to post much again soon, probably better for everyone ha. I appreciate your sentiments. And no hard feelings. I'm learning it's better to agree to disagree with 90% of this board. Just hope I'm wrong! Stevil, hope you don't mind my asking, but are you a physician? Couldn't help but notice your "whitecoat" Cheers, Derek Not yet. Student doctor. Almost there!
|
|
|
Post by falconquest on Nov 9, 2015 20:41:04 GMT -5
Chris-C, To be honest with you, preparation has a lot to do with planning. I don't know how many public speaking gigs you've done, but I know I'm a much,much better speaker when I'm knowledgeable about what I'm talking about. I have more confidence. I don't stumble. I have an answer ready because I've already done all the preparation needed to anticipate. I think the biggest problem with Matt/Hakan is that they're either handcuffed in what they can say/do or they just lack the organizational and visionary skills needed to run a billion dollar company. It's really hard to know where to place the blame, but one would think it must fall directly on their shoulders at some point. If SNY isn't doing what they want or expect from them, they need to be proactive and find a better partner. If they realize that no one wants their "blockbuster" drug, they need to then fully invest in the "embarrassment of riches" and quit wasting time, money, and energy on Afrezza. If it's insurance coverage, then get the deals done already. Time is money. I just don't have confidence in these guys that they have what it takes to run this company. Too many holes that have been evident for too many months. Other companies are getting the job done. It's possible. I hear Chris Viebacher is looking.........(oh wouldn't that piss Sanofi right off)!
|
|
|
Post by dreamboatcruise on Nov 9, 2015 20:52:41 GMT -5
Hard to say how much more SNY could do if they tried, but their marketing and insurance efforts have been subpar. Look no further than Toujeo. When they have a desire to get something done, they get it done. SNY is just as much a problem as our management. There's no doubt in my mind, though, that the script count would be a multiple of what it is now if SNY was dedicated to properly advertising this product. And as some have stated on here before, hire an Apple consultant and make the dreamboat hip and cool. The younger generations are going to be the biggest adopters of Afrezza. With regard to insurance I assume you mean results not effort, correct? or do you know something about their level of effort that is not public? Even for results, what is your metric to judge that it is subpar? I'd be interested what you feel a relevant comparison drug would be and what the coverage looked like this far into a launch.
|
|
|
Post by stevil on Nov 9, 2015 21:03:45 GMT -5
effort and results.
And I referenced Toujeo.
A lot of coverage has to do with contracts. How much the supplier is willing to sell their product for. If SNY doesn't feel they're getting compensated properly, it's all or nothing. So someone has to budge. It's a delicate dance, no doubt, but they don't seem too motivated to get Afrezza covered.
Insurance companies want to cover cheaper drugs. And they want to cover drugs in general. The more coverage they have, the more attractive they are to their potential customers. The ball is in SNY's court here. It's not my job to make the call on how much Afrezza is worth for reimbursement, but I can tell you with certainty that it should be covered by now. It's not any newer of a medication than Toujeo is. It's human insulin. Sure, it's inhaled, but insurance companies don't care about that. If there are any complications due to the inhaled particles, MNKD will get sued and will be responsible for any damages. The FDA has already approved the drug. It's all hinging on contractual agreements over reimbursement. Conveniently, I also worked in revenue at a hospital for 2 years, so I'm somewhat familiar with insurance contracts.
I could be wrong, but that's my understanding off the knowledge and experience I have...
|
|